Mucosal eosinophil abundance in non-inflamed colonic tissue is associated with response to vedolizumab induction therapy in inflammatory bowel disease

HIGHLIGHTS

• who: Ruben Y. Gabriu00ebls et al. from the Department of Gastroenterology and Hepatology, University Medical Center Groningen have published the research: Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease, in the Journal: (JOURNAL) of 19/08/2021
• what: The authors aimed to explore the predictive value of eosinophils and serum eotaxin-1 regarding response to vedolizumab induction therapy. The authors demonstrated that eosinophil abundance in non-inflamed In the present Dutch real-life cohort Dutch discovery cohort. of 84 patients with One IBD . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.